Modern Retina | Ophthalmology News, Events & Expert Insights
October 18th 2024. Thomas Aaberg, Jr, MD, Neurotech's Chief Medical Officer, shared some insights on the company's recent presentation as well as their upcoming presentations at the annual American Academy of Ophthalmology meeting being held in Chicago, Illinois. Steven Yeh, MD, shares overview of recent and upcoming presentations.
AAO 2024: Epimacular membranes and metamorphopsia
1 天前 · AAO 2024: Epimacular membranes and metamorphopsia. October 20, 2024. By Sheryl Stevenson. David Hutton. View All. News. Article. Conference | AAO. At this year's American Academy of Ophthalmology (AAO) meeting, Jonathan Brugger, MD, spoke about the changing approach to epimacular membranes and the use of brilliant blue in the procedure.
AAO 2024: The use of teleretinal screening for diabetic retinopathy ...
1 天前 · Christina Y. Weng, MD, MBA, shared insights from recent publications on teleretinal screenings for diabetic retinopathy. She will be presenting an overview of these findings at the annual American Academy of Ophthalmology meeting being held in Chicago, Illinois during a talk entitled, "The use of teleretinal screening for diabetic retinopathy."
Modern Retina Fall 2024
Sydney M Crago. September 30th 2024. Article. Dilsher Dhoot, MD, sat down with Modern Retina to provide some insights on the phase 1 HELIOS trial, which he presented on during the 2024 ASRS meeting held in Stockholm, Sweden earlier in 2024.
This week in retina: October 29-November 3
2022年11月4日 · In this retrospective, non-comparative clinical study, the investigators evaluated the preoperative, intraoperative, and postoperative data of the 225 study patients (295 eyes; mean patient age, 56.1 years) collected from several European centers. Learn more. An end-of-week review of retina news and stories from October 29-November 3, 2022.
5 top stories from Modern Retina in 2023
2023年12月26日 · The FDA approved intravitreal pegcetacoplan by Apellis in February of 2023, bringing the first GA treatment to those affected by the condition and empowering retina specialists with a new tool to combat the disease. Iveric Bio’s avacincaptad pegol joined the treatment options in August, when it was approved by the FDA.
Light therapy: Potential treatment for dry AMD
3 天之前 · Light therapy: Potential treatment for dry AMD. The results of a new study has shown that photobiomodulation, a non-invasive treatment, may be another method for treating dry age-related macular degeneration (AMD). David S. Boyer, MD, of Retina-Vitreous Associates Medical Group in Los Angeles, reported that this therapy can reduce the risk of ...
News - Modern Retina
AAO 2024: Centricity Vision to unveil new ZEPTOLink enhancements for improved efficiency and control. David Hutton. October 15th 2024. Centricity Vision announced new ZEPTOLink enhancements, reducing treatment time by up to 60%. These updates, aimed at improving cataract surgery efficiency and control, will be showcased at the 2024 American ...
Modern Retina Fall 2022
Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Modern Retina Spring 2022
2022年3月15日 · Reshaping retina treatment with faricimab. Lynda Charters. March 14th 2022. Article. The first FDA-approved bispecific antibody for the eye targets two leading causes of vision loss. Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.